Oral Presentation

[26M-am] Inflammation and immune system-1

Sat. Mar 26, 2022 9:30 AM - 10:42 AM [Room M] Conference Room 232 (Bldg. 2: 3F)

Chair: Yoshihiro Hayakawa

+Add all to schedule

9:30 AM - 9:42 AM

[26M-am01] Effect of Orengedokuto on dermatitis and itch-related responses in mice with atopy-like dermatitis

○Tsugunobu Andoh¹, Yoko Yoshihisa², Tadamichi Shimizu² (1. Coll. Pharm., Kinjo Gakuin Univ., 2. Grad. Sch. Med., Univ. Toyama )

9:42 AM - 9:54 AM

[26M-am02S] Suppressive effect of kamebakaurin on chemical mediator release from FcεRI-aggregated mast cells.

○Kaho Hatsukawa¹, Nanami Murakami¹, Naoko Takeda¹, Mayu Miyasaka¹, Saaya Suzuki¹, Yutaka Aoyagi¹, Yukio Hitotuyanagi², Koichi Takeya², Ming-yu Gui³, Yong-Ri Jin³, Xu-Wen Li³, Haruka Asai¹, Nobuyuki Fukuishi¹ (1. Col. Pharm. Kinjo Gakuin Univ., 2. Sch. Pharm. Tokyo Univ. of Pharm. and Life Sci., 3. Col. Chem. JiLin Univ.)

9:54 AM - 10:06 AM

[26M-am03S] Mechanism of decreased degranulation ratio after FceRI aggregation in mast cells generated from ABCA1 or ABCA7 knock out mouse

○Mao Kawaguchi¹, Hinano Murai¹, Marisa Hirose¹, Reina Isomura¹, Hikari Sato¹, Sumiko Dohmae², Haruka Asai¹, Nobuyuki Fukuishi¹ (1. Col. of Pharm. Kinjo Gakuin Univ., 2. Col. of Biosci. and Biotech. Chubu Univ.)

10:06 AM - 10:18 AM

[26M-am04S] Identification of a molecular target of mast cell stabilizers

○Masumi Oka¹, Sota Akaki², Yuki Akeno², Osamu Ono³, Maho Terasaki¹, Shoya Mizuko², Yuho Tamura¹, Kazuyuki Furuta², Kenji Matsuno³, Satoshi Tanaka¹ (1. Kyoto Pharm. Univ., 2. Grad. Sch. Med. Dent. Pharm. Sci., Okayama Univ., 3. Sch. Adv. Eng., Kogakuin Univ.)

10:18 AM - 10:30 AM

[26M-am05] P2X4 receptor signaling enhanced psuedallergyc response

○Kazuki Yoshida¹, Syota Tanihara¹, Tomoki Miyashita¹, Kosuke Obayashi¹, Masa-aki Ito¹, Isao Matsuoka¹ (1. Fac. Pharm. Takasaki univ. of health and welfare)

10:30 AM - 10:42 AM

[26M-am06] Identification of action targets that contribute to the suppression of TSLP expression by chalcone derivatives

○Ryosuke Segawa¹, Hiroyuki Takeda², Takeshi Yokoyama³, Momoha Ishida¹, Chihiro Miyata¹, Taiji Saito¹, Ryosuke Ishihara¹, Tomoya Nakagita², Yusuke Sasano⁴, Naoki Kanoh⁵, Yoshiharu Iwabuchi⁴, Mineyuki Mizuguchi³, Masahiro Hiratsuka¹, Noriyasu Hirasawa¹ (1. Laboratory of Pharmacotherapy of Life-Style Related Diseases, Graduate School of Pharmaceutical Sciences, Tohoku University, 2. Proteo-Science Center, Ehime University, 3. Laboratiry of Structural Biology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 4. Laboratory of Synthetic Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, 5. Laboratory of Organic and Biomolecular Chemistry, School of Pharmacy and Pharmaceutical Sciences, and Institute of Medical Chemistry, Hoshi University)

Session information